1Forman D, Burley VJ. Gastric cancer:global pattern of the disease and an overview of environmental risk factors. Best Pratt Res Clin Gastroenterol, 2006, 20:633-649.
3Miwa M,Ura M, Nishida M,et al. Design of a novel aralifluracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer, 1998, 34:1274-1281.
4Folkman J. Angiogenesis. Annu Rev Med, 2006,57 : 1-18.
5Yonenaga F,Takasaki T, Ohi Y, et al. The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer. Pathol Int,1998,48:850- 856.
7Mattern J,Koommagi R,Volm M. Biological characterization of subgroups of squamous cell lung carcinomas[J].Clin Cancer Res,1999,5(6): 1459.
8Miwa M,Ura M,Nishida M,et al. Design of novel oral fluoropyrimidine carbamate capecitabine,which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue[J].Eur J Cancer,1998,34(8):1274.
9Koizumi W,Salgenji K,Nakamaru N,et al. Prediction of response to 5-deoxy-5-fluorouridine (5-DFUR) in patients with inoperable advance gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor[J]. Oncology,1999,56(3):215.
10Okamoto E,Osaki M,Kase S,et al. Thymidine phosphorylase expression causes both the increase of intratumoral microvessel and decrease of apoptosis in human esophageal carcinomas[J].Pathology,2001,51(3):158.
